Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial.
Saved in:
| Title: | Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial. |
|---|---|
| Authors: | Lipton RB; Departments of Neurology, Psychiatry and Behavioral Sciences, and the Montefiore Headache Center, Albert Einstein College of Medicine, New York, New York., Ramirez Campos V; Teva Branded Pharmaceutical Products R&D Inc, West Chester, Pennsylvania., Roth-Ben Arie Z; Teva Pharmaceutical Industries Ltd, Tel Aviv, Israel., Galic M; Teva-Pharma, Produtos Farmacêuticos, Lda, Porto Salvo, Portugal., Mitsikostas D; Department of First Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece., Tassorelli C; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; IRCCS Mondino Foundation, Pavia, Italy., Denysenko L; Department of Neurology, Jefferson Headache Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.; Department of Psychiatry and Human Behavior, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Cohen JM; Braeburn Inc, Plymouth Meeting, Pennsylvania. |
| Source: | JAMA neurology [JAMA Neurol] 2025 Jun 01; Vol. 82 (6), pp. 560-569. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6157 |
|---|---|
| DOI: | 10.1001/jamaneurol.2025.0806 |
